180 Wealth Advisors, LLC Tekla Life Sciences Investors Transaction History
180 Wealth Advisors, LLC
- $789 Million
- Q3 2025
A detailed history of 180 Wealth Advisors, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 149,258 shares of HQL stock, worth $2.49 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
149,258
Previous 143,098
4.3%
Holding current value
$2.49 Million
Previous $1.83 Million
26.24%
% of portfolio
0.29%
Previous 0.26%
Shares
27 transactions
Others Institutions Holding HQL
# of Institutions
91Shares Held
9.36MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.59MShares$43.1 Million1.2% of portfolio
-
Morgan Stanley New York, NY871KShares$14.5 Million0.0% of portfolio
-
Penserra Capital Management LLC Orinda, CA794KShares$13.2 Million0.16% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL423KShares$7.04 Million0.0% of portfolio
-
Needham Investment Management LLC New York, NY403KShares$6.72 Million0.5% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...